Sign in

CIK 0001048477

  • Large accelerated filer

BIOMARIN PHARMACEUTICAL INC

Sign in to watch
Ticker
BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680397820
Phone
+1 415-506-6700
Business address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,163,748
in 1 filing

Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Davis George Eric −$1.2M EVP, Chief Legal Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-16 Mueller Brian EVP, Chief Financial Officer Shares withheld for taxes −3,973 $93.41 $371K 55,585
2023-03-16 FUCHS HENRY J President, Worldwide R&D Shares withheld for taxes −36,000 $93.41 $3.4M 188,187
2023-03-16 Davis George Eric EVP, Chief Legal Officer Shares withheld for taxes −19,957 $93.41 $1.9M 80,367
2023-03-16 BIENAIME JEAN JACQUES Chief Executive Officer Shares withheld for taxes −88,623 $93.41 $8.3M 425,896
2023-03-16 Ajer Jeffrey Robert EVP, Chief Commercial Officer Shares withheld for taxes −20,510 $93.41 $1.9M 65,486
2023-03-15 Guyer Charles Greg EVP, Chief Technical Officer Grant or award +8,900 51,320
2023-03-15 Guyer Charles Greg EVP, Chief Technical Officer Shares withheld for taxes −1,856 $87.74 $163K 49,464
2023-03-15 Guyer Charles Greg EVP, Chief Technical Officer Grant or award · Stock Option (Right to buy Common Stock) +20,320 20,320
2023-03-15 Mueller Brian EVP, Chief Financial Officer Grant or award +9,630 62,266
2023-03-15 Mueller Brian EVP, Chief Financial Officer Shares withheld for taxes −2,708 $87.74 $238K 59,558
2023-03-15 Mueller Brian EVP, Chief Financial Officer Grant or award · Stock Option (Right to buy Common Stock) +21,970 21,970
2023-03-15 FUCHS HENRY J President, Worldwide R&D Grant or award +16,840 228,986
2023-03-15 FUCHS HENRY J President, Worldwide R&D Shares withheld for taxes −4,799 $87.74 $421K 224,187
2023-03-15 FUCHS HENRY J President, Worldwide R&D Grant or award · Stock Option (Right to buy Common Stock) +38,450 38,450
2023-03-15 Davis George Eric EVP, Chief Legal Officer Grant or award +8,900 103,349
2023-03-15 Davis George Eric EVP, Chief Legal Officer Shares withheld for taxes −3,025 $87.74 $265K 100,324
2023-03-15 Davis George Eric EVP, Chief Legal Officer Grant or award · Stock Option (Right to buy Common Stock) +20,320 20,320
2023-03-15 Burkhart Erin GVP, Chief Accounting Officer Grant or award +3,760 14,890
2023-03-15 Burkhart Erin GVP, Chief Accounting Officer Grant or award · Stock Option (Right to buy Common Stock) +5,720 5,720
2023-03-15 BIENAIME JEAN JACQUES Chief Executive Officer Grant or award +36,100 523,956

Page 16 of 23 · 450 trades